Q&A on the Future of Cell Therapy Manufacturing

Overview

In this Q&A, Sara Morlacchi, AGC Biologics’
Cell Process Development Manager, provides her expert analysis on the current state of the cell therapy space, the growth of the industry, and barriers for cost and accessibility. 

Download this white paper to learn how cell therapy is becoming more industrialized and what this means for developers.

Key Takeaways

• Common processes and challenges facing cell therapy developers & manufacturers

• Technologies needed to improve success rates of therapies 

• Trends in the cell therapy space that will alter the future of the industry

• Looking into the future of the cell therapy industry